PLASMODIUM VIVAX MALARIA
Clinical trials for PLASMODIUM VIVAX MALARIA explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM VIVAX MALARIA trials appear
Sign up with your email to follow new studies for PLASMODIUM VIVAX MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Whole-Village drug dosing aims to stamp out malaria
Disease control CompletedThis study tested giving a single dose of the drug tafenoquine to everyone in three villages in Myanmar to control malaria. Over 1,200 people took part. The goal was to see if this approach is safe and practical, and if it could reduce malaria cases in the area.
Matched conditions: PLASMODIUM VIVAX MALARIA
Phase: PHASE4 • Sponsor: Shoklo Malaria Research Unit • Aim: Disease control
Last updated May 17, 2026 11:31 UTC
-
Mass drug trial aims to stamp out malaria in Thailand's hotspots
Prevention CompletedThis study tested whether giving malaria drugs to people at high risk—like those living in villages or working in forests—could lower malaria rates in their communities. Over 14,000 people in five Thai provinces took part. Researchers compared areas that received this targeted dr…
Matched conditions: PLASMODIUM VIVAX MALARIA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated May 17, 2026 11:35 UTC